GlassScriptPhysician profile
Blaine K Jackson
NPI 1518079565
$9,835.72
in general payments reported to CMS, 2019-2025
42 companies · $2,546 in 2025
The $2,546 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $806 · 2020: $458 · 2021: $1,874 · 2022: $1,649 · 2023: $1,319 · 2024: $1,184 · 2025: $2,546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,972 · Education: $74.35 · Travel and Lodging: $2.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,971.77 |
| Education | $74.35 |
| Travel and Lodging | $2.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,444.75 | 2021-2025 | Ingrezza |
| Lilly USA, LLC | $1,374.75 | 2019-2025 | Zepbound, Kisunla, Mounjaro |
| Teva Pharmaceuticals USA, INC. | $1,059.47 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Otsuka America Pharmaceutical, INC. | $1,008.40 | 2021-2025 | Rexulti, Nuedexta |
| Abbvie INC. | $845.80 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $682.28 | 2023-2025 | Nuplazid |
| Bayer Healthcare Pharmaceuticals INC. | $608.22 | 2021-2024 | |
| Pfizer INC. | $386.06 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $381.27 | 2019-2023 | |
| Eisai INC. | $199.30 | 2020-2022 | |
| Avanir Pharmaceuticals, INC. | $145.56 | 2019 | |
| Amarin Pharma, INC. | $143.26 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $133.78 | 2023-2025 | Belbuca, Xtampza |
| E.R. Squibb & Sons, L.L.C. | $125.06 | 2025 | Cobenfy |
| Biohaven Pharmaceuticals, INC. | $124.44 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaine Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.